The main problem with taking drugs that are not properly tested or have no long-term studies is that unintended consequences happen.

Singer Avery shared an emotional message to her followers after receiving news that Ozempic has left her with osteoporosis.

According to NDTV:

In an emotional Instagram video, singer Avery tearfully revealed that she has been diagnosed with a debilitating bone-thinning disease after taking Ozempic for a year. The 30-year-old Arizona native confessed that she turned to the weight-loss drug after battling an eating disorder.

The singer shared that she was dropped by her record label for "being too fat" and confessed, "I thought I needed Ozempic to be beautiful and successful.”

There’s never a reason to blame the victim, but it’s unclear to what extent the medication played in this, considering she had an eating disorder prior. However, she implies her doctors have stated that it’s a result of taking the medication.

Recent tests revealed she has osteoporosis, a condition that increases the risk of life-threatening fractures.

In her video, she urged her 250,000 Instagram followers not to "make the same mistake" and take a medication "you do not need."

In a separate post, she wrote, "Please, please be careful with Ozempic if you don't need it. It's meant only for diabetes and obesity treatment. I've done a lot of damage to myself. I want to make it clear that I do have an eating disorder and did NOT get Ozempic from a doctor. It's very easy to get now, and many people with eating disorders are using it. I made a mistake, and I take responsibility for it. Please learn from mine.

For some, the benefits may outweigh the risks, but there is always a risk. And the fact that doctors approved this for her when she was likely not even overweight is deeply concerning.

According to Fred Hutch Cancer Center,

There are thyroid cancer concerns associated with semaglutides, and as a result, the FDA has boxed warnings on these products.

Ozempic, for instance, warns of “possible thyroid tumors, including cancer” and specifically advises those at risk for medullary thyroid carcinoma or multiple endocrine neoplastic syndrome type 2 to avoid these drugs.

So, while the bureaucracy would love it if the obese masses were to jump on the semaglutide train, the risk is not fully understood. Many of these effects could be prevented if people do this by fixing their diet and exercise. And although all of this is painfully obvious, many people will unfortunately learn this the hard way.

The fact that “scientists haven't figured out the precise mechanism for the way these medicines” work proves that they only know what they know, which is that it helps aid in weight loss. However, this also proves what they don’t know, which is that it could lead to life-long consequences like bone disease.

- YouTubewww.youtube.com